Table 2 The secondary structure details and the subcellular localization of the STAG3 peptides
From: Characterization of the major human STAG3 variants using some proteomics and bioinformatics assays
Isoform ID | Secondary structure details | |||
|---|---|---|---|---|
α-Helix | Random coils | Extended strands | β-Turns | |
1, 201, 206 | 60.00% | 34.37% | 3.76% | 1.88% |
2, X3, 218 | 59.95% | 34.34% | 3.92% | 1.79% |
3, 202, 219 | 61.18% | 33.08% | 4.37% | 1.37% |
X1 | 59.16% | 34.30% | 4.44% | 2.10% |
X2 | 59.94% | 34.25% | 3.96% | 1.86% |
X4 | 61.44% | 32.80% | 4.66% | 1.10% |
Predicted subcellular localization | ||||
Isoform/possibility % | Subcellular localization | |||
1, 2, X1, X2, X3, 206, 201, 218 | 3, X4, 202, 219 | |||
22.2% | 17.4% | Vacuolar | ||
11.1% | 4.3% | Cytoplasmic | ||
11.1% | 4.3% | Cytoskeletal | ||
11.1% | 4.3% | Mitochondrial | ||
11.1% | 21.7%1 | Endoplasmic reticulum | ||
11.1% | 4.3% | Golgi | ||
11.1% | 17.4% | Nuclear | ||
11.1% | 26.1% | Plasma membrane | ||